News Detail
MINNEAPOLIS, 27 APRIL 2024: People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neuro......
View Details
Source : American Academy of Neurology
acid reflux drugs
proton pump inhibitors
University of Maryland
acid-reducing medicines
Neurology Clinical Practice
American Academy of Neurology
antacid supplements
gastroesophageal reflux
histamine H2-receptor
Health news
Related News
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)
- Human body's protein recycling system fights bacteria like antibiotics: Study (06-03-2025)
- Researchers at IIT Kanpur Identify Crucial Drug Target Receptor for Treating Cancer and Respiratory Diseases (22-02-2025)
- Polymer coating designed to prevent blood clot formation on medical implants (21-02-2025)
- Repurposing amlodipine, could help manage ADHD symptoms: Study (20-02-2025)
- Fluoxetine promotes IL-10–dependent metabolic defenses to protect from sepsis-induced lethality (16-02-2025)